EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $65,000 | -51.5% | 35,890 | -55.9% | 0.00% | – |
| Q2 2019 | $134,000 | -80.2% | 81,455 | -78.5% | 0.00% | -100.0% |
| Q1 2019 | $678,000 | -46.6% | 378,780 | -43.6% | 0.00% | 0.0% |
| Q4 2018 | $1,269,000 | -65.9% | 671,625 | -35.6% | 0.00% | -75.0% |
| Q3 2018 | $3,724,000 | +59.2% | 1,043,000 | -7.2% | 0.00% | +300.0% |
| Q2 2018 | $2,339,000 | – | 1,124,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |